Sevagyan Medi Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Gwalior, Madhya Pradesh, India, established in 2015.
2015 Gwalior, Madhya Pradesh, India Struck Off
Last Updated:
About Sevagyan Medi Pharma Private Limited

Sevagyan Medi Pharma Private Limited, a struck off private limited company, was established on 27 January 2015 in Gwalior, Madhya Pradesh, India. Engaging in medical & surgical equipment within the healthcare sector, it holds CIN: U33110MP2015PTC033747. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Manoj Kumar Sagar (Director), Arun Kumar Sagar (Director). Past directors included Sovaran Singh. It is based at 2Nd Phase, O-4/80 Shatabdipuram, Gwalior, Madhya Pradesh, 474005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110MP2015PTC033747

  • Registration Number

    033747

  • Incorporation Date

    27 January 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 27 Days
Company report

Sevagyan Medi Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sevagyan Medi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sevagyan Medi Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Kumar Sagar Director 05 Sep 2015 Current
Arun Kumar Sagar Director 27 Jan 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sevagyan Medi Pharma.

Enhance accessibility to Sevagyan Medi Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sevagyan Medi Pharma revenue growth over time
Sevagyan Medi Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sevagyan Medi Pharma?

Unlock access to Sevagyan Medi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sevagyan Medi Pharma?

Unlock and access historical data on people associated with Sevagyan Medi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sevagyan Medi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sevagyan Medi Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sevagyan Medi Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Manoj Kumar Sagar was appointed as a Director was appointed as a Director on 05 Sep 2015 & has been associated with this company since 10 years 5 months . was completed.

  • Director Appointment

    Arun Kumar Sagar was appointed as a Director was appointed as a Director on 27 Jan 2015 & has been associated with this company since 11 years 27 days . was recorded as a recent event.

  • Company Incorporation

    The activity Sevagyan Medi Pharma Private Limited was registered on 27 Jan 2015 with Roc Gwalior & aged 11 years 27 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sevagyan Medi Pharma Private Limited?

The CIN of Sevagyan Medi Pharma Private Limited is U33110MP2015PTC033747.

Where is Sevagyan Medi Pharma Private Limited headquartered?

Sevagyan Medi Pharma Private Limited is headquartered at 2Nd Phase, O-4/80 Shatabdipuram, Gwalior, Madhya Pradesh, 474005.

When was Sevagyan Medi Pharma Private Limited incorporated?

Sevagyan Medi Pharma Private Limited was incorporated on 27 January 2015.

Who are the current directors of Sevagyan Medi Pharma Private Limited?

The current directors of Sevagyan Medi Pharma Private Limited are

What is the primary industry of Sevagyan Medi Pharma Private Limited?

The primary industry of Sevagyan Medi Pharma Private Limited is Healthcare.

Is Sevagyan Medi Pharma Private Limited a listed company?

Sevagyan Medi Pharma Private Limited is unlisted.

What is the capital structure of Sevagyan Medi Pharma Private Limited?

The authorized capital of Sevagyan Medi Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sevagyan Medi Pharma Private Limited?

The compliance status of Sevagyan Medi Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available